Subscribe to RSS
DOI: 10.1055/s-0043-1770163
Prenatal Diagnosis of Chromosomal Mosaicism in 18,369 Cases of Amniocentesis
Funding None.Abstract
Objective The prenatal diagnosis of chromosomal mosaicism is fraught with uncertainty. Karyotyping, chromosomal microarray analysis (CMA), and fluorescence in situ hybridization (FISH) are three commonly used techniques. In this study, we evaluated these techniques for the prenatal diagnosis of chromosomal mosaicism and its clinical outcome.
Study Design A retrospective review of mosaicism was conducted in 18,369 pregnant women from January 2016 to November 2021. The subjects underwent amniocentesis to obtain amniotic fluid for G-band karyotyping with or without CMA/FISH. Cases diagnosed with chromosomal mosaicism were selected for further analysis.
Results In total, 101 cases of chromosomal mosaicism were detected in 100 pregnant women (0.54%, 100/18,369). Four were lost during follow-up, 61 opted to terminate their pregnancy, and 35 gave birth to a healthy singleton or twins. Among these 35 cases, postnatal cytogenetic testing was performed on eight and two exhibited mosaicism; however, nothing abnormal was observed in the postnatal phenotype follow-up. Karyotyping identified 96 incidents of chromosomal mosaicism including 13 with level II mosaicism and 83 with level III mosaicism, FISH identified 37 cases of mosaicism, and CMA identified 17. The most common form of chromosomal mosaicism involved monosomy X, of which the mosaic fraction in cultured karyotyping appeared higher or comparable to uncultured FISH/CMA (p < 0.05). Discordant mosaic results were observed in 34 of 101 cases (33.7%), most of which resulted from the detection limit of different techniques and/or the dominant growth of a certain cell line.
Conclusion Based on the postnatal follow-up results from the babies born, we obtained a more hopeful result for the prognosis of chromosomal mosaicism. Although karyotyping was the most sensitive method for detecting chromosomal mosaicism, artifacts and bias resulting from culture should be considered, particularly for sex chromosomal abnormalities involving X monosomy, in which the combination with uncultured FISH was necessary.
Key Points
-
Karyotyping combined with uncultured FISH or CMA is beneficial for prenatal diagnosis of chromosomal mosaicism.
-
Fetuses without ultrasound structural anomalies with chromosomal mosaicism often have optimistic prognosis.
Keywords
chromosomal mosaicism - karyotyping - chromosomal microarray analysis - fluorescence in situ hybridization analysis - prenatal diagnosis - dominant growthPublication History
Received: 01 August 2022
Accepted: 19 May 2023
Article published online:
19 June 2023
© 2023. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
Reference
- 1 Grati FR. Chromosomal mosaicism in human feto-placental development: implications for prenatal diagnosis. J Clin Med 2014; 3 (03) 809-837
- 2 Levy B, Hoffmann ER, McCoy RC, Grati FR. Chromosomal mosaicism: origins and clinical implications in preimplantation and prenatal diagnosis. Prenat Diagn 2021; 41 (05) 631-641
- 3 Benn P, Malvestiti F, Grimi B, Maggi F, Simoni G, Grati FR. Rare autosomal trisomies: comparison of detection through cell-free DNA analysis and direct chromosome preparation of chorionic villus samples. Ultrasound Obstet Gynecol 2019; 54 (04) 458-467
- 4 Malvestiti F, Agrati C, Grimi B. et al. Interpreting mosaicism in chorionic villi: results of a monocentric series of 1001 mosaics in chorionic villi with follow-up amniocentesis. Prenat Diagn 2015; 35 (11) 1117-1127
- 5 Weremowicz S, Sandstrom DJ, Morton CC, Niedzwiecki CA, Sandstrom MM, Bieber FR. Fluorescence in situ hybridization (FISH) for rapid detection of aneuploidy: experience in 911 prenatal cases. Prenat Diagn 2001; 21 (04) 262-269
- 6 Levy B, Wapner R. Prenatal diagnosis by chromosomal microarray analysis. Fertil Steril 2018; 109 (02) 201-212
- 7 Oneda B, Rauch A. Microarrays in prenatal diagnosis. Best Pract Res Clin Obstet Gynaecol 2017; 42: 53-63
- 8 Riggs ER, Andersen EF, Cherry AM. et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med 2020; 22 (02) 245-257
- 9 Del Gaudio D, Shinawi M, Astbury C, Tayeh MK, Deak KL, Raca G. ACMG Laboratory Quality Assurance Committee. Diagnostic testing for uniparental disomy: a points to consider statement from the American College of Medical Genetics and Genomics (ACMG). Genet Med 2020; 22 (07) 1133-1141
- 10 Ma N, Xi H, Chen J. et al. Integrated CNV-seq, karyotyping and SNP-array analyses for effective prenatal diagnosis of chromosomal mosaicism. BMC Med Genomics 2021; 14 (01) 56
- 11 Chen CP, Su YN, Chern SR. et al. Mosaic trisomy 2 at amniocentesis: prenatal diagnosis and molecular genetic analysis. Taiwan J Obstet Gynecol 2012; 51 (04) 603-611
- 12 Magenis E, Webb MJ, Spears B, Opitz JM. Blaschkolinear malformation syndrome in complex trisomy-7 mosaicism. Am J Med Genet 1999; 87 (05) 375-383
- 13 Jia CW, Wang SY, Ma YM. et al. Fluorescence in situ hybridization in uncultured amniocytes for detection of aneuploidy in 4210 prenatal cases. Chin Med J (Engl) 2011; 124 (08) 1164-1168
- 14 Zhang Y, Lei Q, Liu J. et al. Selective growth of mosaic cells in chromosomal analysis of chorionic villi by conventional karyotyping. Mol Cell Probes 2020; 51: 101532
- 15 Cremer M, Treiss I, Cremer T, Hager D, Franke WW. Characterization of cells of amniotic fluids by immunological identification of intermediate-sized filaments: presence of cells of different tissue origin. Hum Genet 1981; 59 (04) 373-379
- 16 Van Opstal D, van den Berg C, Galjaard RJ, Los FJ. Follow-up investigations in uncultured amniotic fluid cells after uncertain cytogenetic results. Prenat Diagn 2001; 21 (02) 75-80
- 17 Langlois S, Yong PJ, Yong SL. et al. Postnatal follow-up of prenatally diagnosed trisomy 16 mosaicism. Prenat Diagn 2006; 26 (06) 548-558
- 18 Wallerstein R, Misra S, Dugar RB, Alem M, Mazzoni R, Garabedian MJ. Current knowledge of prenatal diagnosis of mosaic autosomal trisomy in amniocytes: karyotype/phenotype correlations. Prenat Diagn 2015; 35 (09) 841-847
- 19 Wallerstein R, Twersky S, Layman P. et al. Long term follow-up of developmental delay in a child with prenatally-diagnosed trisomy 20 mosaicism. Am J Med Genet A 2005; 137 (01) 94-97
- 20 Cassina M, Calò A, Salviati L, Alghisi A, Montaldi A, Clementi M. Prenatal detection of trisomy 8 mosaicism: Pregnancy outcome and follow up of a series of 17 consecutive cases. Eur J Obstet Gynecol Reprod Biol 2018; 221: 23-27
- 21 Bertelloni S, Baroncelli GI, Massart F, Toschi B. Growth in boys with 45,X/46,XY mosaicism: effect of growth hormone treatment on statural growth. Sex Dev 2015; 9 (04) 183-189
- 22 Noordman ID, van der Velden JA, Timmers HJ. et al. Karyotype—phenotype associations in patients with Turner syndrome. Pediatr Endocrinol Rev 2019; 16 (04) 431-440
- 23 Tuke MA, Ruth KS, Wood AR. et al. Mosaic Turner syndrome shows reduced penetrance in an adult population study. Genet Med 2019; 21 (04) 877-886
- 24 Zhang Y, Zhong M, Zheng D. Chromosomal mosaicism detected by karyotyping and chromosomal microarray analysis in prenatal diagnosis. J Cell Mol Med 2021; 25 (01) 358-366
- 25 Vogel I, Vestergaard EM, Lildballe DL. et al. Placental mosaicism in the era of chromosomal microarrays. Eur J Med Genet 2020; 63 (04) 103778
- 26 Alesi V, Dentici ML, Restaldi F. et al. Unclassifiable pattern of hypopigmentation in a patient with mosaic partial 12p tetrasomy without Pallister-Killian syndrome. Am J Med Genet A 2017; 173 (07) 1943-1946
- 27 Rodríguez-Martín C, Robledo C, Gómez-Mariano G. et al. Frequency of low-level and high-level mosaicism in sporadic retinoblastoma: genotype-phenotype relationships. J Hum Genet 2020; 65 (02) 165-174